The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/28061
StudyName: Eligibility Chronic Lymphocytic Leukemia NCT00628238
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 13.12.2017
License: Creative Commons BY 4.0

----

Description: 
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00628238
